GIP/GLP-1 receptor agonist combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GIP/GLP-1 receptor agonist combination, covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes [Phase 3]